Viewing Study NCT06560528

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:32 AM
Ignite Modification Date: 2026-02-02 @ 11:32 AM
Study NCT ID: NCT06560528
Status: RECRUITING
Last Update Posted: 2024-08-19
First Post: 2024-08-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Cancer View
None Gastroesophageal Junction Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RC48-ADC View
None HER2 View